Omalizumab for the treatment of chronic inducible urticaria in 80 patients.

Vicente Exposito-Serrano Laia Curto-BarredoP Aguilera PeiroS Gómez ArmayonesE Serra-BaldrichJ SpertinoM Bonfill OrtíI Figueras NartGemma Melé-NinotC Baliu-PiquéA Sala CunillM Labrador-HorrilloA Guilabert VidalN Fernández ChicoA M Giménez-Arnau

Published in: The British journal of dermatology (2020)

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis